Ocular Therapeutix Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Ocular Therapeutix, Inc. (OCUL) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-265.94-193.51-80.74-71.04-6.55-155.64-86.37-59.98
Depreciation & Amortization4.323.799.096.962.422.776.212.29
Stock Based Compensation43.1833.1117.8316.9614.987.530.000.00
Change in Working Capital7.71-10.23-7.171.80-2.901.18-1.760.59
Change in Accounts Receivable1.74-6.21-4.85-0.19-8.88-9.700.000.00
Change in Inventory-0.52-0.74-0.33-0.72-0.05-0.250.000.00
Change in Accounts Payable-0.89-0.320.58-0.621.80-0.450.000.00
Change in Other Working Capital7.513.736.111.923.24-0.420.000.00
Other Operating Activities5.873.7322.772.68-73.4990.608.650.40
Net Cash from Operating Activities-204.88-134.68-70.23-59.60-65.55-53.55-77.58-49.23
Investing Activities
Capital Expenditures-12.01-1.296.093.72-1.19-0.842.24-1.89
Other Investing Activities0.130.000.000.000.000.000.000.00
Net Cash from Investing Activities-11.88-1.29-6.09-3.72-1.19-0.84-2.24-1.89
Financing Activities
Debt Repayment0.00316.35-28.130.00-4.17-3.200.00-5.66
Common Stock Issued561.72317.37118.111.453.57228.0137.5461.57
Other Financing Activities0.00-300.602.000.00-0.280.000.000.00
Net Cash from Financing Activities561.72332.11169.831.452.85228.0175.3468.64
Summary
Net Change in Cash344.96196.1593.51-61.86-63.89173.62-4.4817.52
Cash at Beginning of Period393.72197.57104.06165.93229.8256.2060.6843.15
Cash at End of Period738.67393.72-74.32104.06165.93229.8256.2060.68
Free Cash Flow-216.89-135.97-76.32-63.32-66.74-54.40-79.82-51.12
Supplemental Disclosures
Interest Paid0.0021.535.462.151.932.352.301.52